Trip Terminator: Difference between revisions
From BurnZero
(Created page with "'''Kentanserin''' a research chemical and antagonist of 5-HT2A binds to the main psychedelic receptor but does not activate it. A recent study showed that giving participants kentanserin 1 hour after giving them LSD reduced the duration of LSD's subjective effects from around 8.5 hours to 3.5 hours<ref>'''Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects'''. Anna M Becker, Aaron Klaiber, F...") |
mNo edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Kentanserin''' a research chemical and antagonist of 5-HT2A binds to the main psychedelic receptor but does not activate it. A recent study showed that giving participants kentanserin 1 hour after giving them LSD reduced the duration of LSD's subjective effects from around 8.5 hours to 3.5 hours<ref>'''Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects'''. Anna M Becker, Aaron Klaiber, Friederike Holze, Ioanna Istampoulouoglou, Urs Duthaler, Nimmy Varghese, Anne Eckert, Matthias E Liechti. ''International Journal of Neuropsychopharmacology'', 2022;, pyac075, <nowiki>https://doi.org/10.1093/ijnp/pyac075</nowiki></ref>. In theory, kentanserin might have use for reducing or terminating a psychedelic experience. | '''Kentanserin and olanzapine'''<ref>'''Olanzapine as the ideal “trip terminator”?''' Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani. First published: 28 July 2015 <nowiki>https://doi.org/10.1002/hup.2431</nowiki>. Accessed via: <nowiki>https://onlinelibrary.wiley.com/doi/10.1002/hup.2431</nowiki></ref> '''have been found to stop [[Psychedelics|psychedelic]] trips.''' | ||
Olanzapine is an atypical antipsychotic. Kentanserin a research chemical and antagonist of 5-HT2A binds to the main psychedelic receptor but does not activate it. A recent study showed that giving participants kentanserin 1 hour after giving them LSD reduced the duration of LSD's subjective effects from around 8.5 hours to 3.5 hours<ref>'''Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects'''. Anna M Becker, Aaron Klaiber, Friederike Holze, Ioanna Istampoulouoglou, Urs Duthaler, Nimmy Varghese, Anne Eckert, Matthias E Liechti. ''International Journal of Neuropsychopharmacology'', 2022;, pyac075, <nowiki>https://doi.org/10.1093/ijnp/pyac075</nowiki></ref>. In theory, kentanserin might have use for reducing or terminating a psychedelic experience. | |||
'''References''' | |||
<references /> | |||
Latest revision as of 03:38, 12 December 2022
Kentanserin and olanzapine[1] have been found to stop psychedelic trips.
Olanzapine is an atypical antipsychotic. Kentanserin a research chemical and antagonist of 5-HT2A binds to the main psychedelic receptor but does not activate it. A recent study showed that giving participants kentanserin 1 hour after giving them LSD reduced the duration of LSD's subjective effects from around 8.5 hours to 3.5 hours[2]. In theory, kentanserin might have use for reducing or terminating a psychedelic experience.
References
- ↑ Olanzapine as the ideal “trip terminator”? Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani. First published: 28 July 2015 https://doi.org/10.1002/hup.2431. Accessed via: https://onlinelibrary.wiley.com/doi/10.1002/hup.2431
- ↑ Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Anna M Becker, Aaron Klaiber, Friederike Holze, Ioanna Istampoulouoglou, Urs Duthaler, Nimmy Varghese, Anne Eckert, Matthias E Liechti. International Journal of Neuropsychopharmacology, 2022;, pyac075, https://doi.org/10.1093/ijnp/pyac075